Skip to main content

Advertisement

Table 2 Baseline characteristics comparison within Cohort 2 (PP vs MD groups)

From: Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT

Characteristic Cohort 2 (PP)
N = 103
Cohort 2 (MD)
N = 33
P value
Age, (years) mean ± SD 66 ± 9.1 65 ± 6.2 NS
Male gender, N (%) 69 (67%) 26 (79%) NS
Weight, (kg) mean ± SD 87 ± 20.8 97 ± 23.9 < 0.035
BMI, (kg/m2) mean ± SD 30.3 ± 6.2 32 ± 7.6 NS
Diabetes type, N (%)
- Type 1 8 (7.8%) 2 (6.1%) NS
- Type 2 90 (87.4%) 30 (90.9%) NS
- Unknown 5 (4.9%) 1 (3%) NS
Diabetes therapy, N (%)
- Insulin 39 (37.9%) 23 (69.7%) < 0.002
- Oral therapy 57 (55.3%) 9 (27.3%) NS
BGL, (mmol/L)
- Mean ± SD 14.2 ± 2.7 14.8 ± 2.3 NS
- Range 10.4–24.3 10.4–19.5  
  1. PP per protocol, MD modified dose, SD standard deviation, N number, BMI body mass index, BGL blood glucose level, NS not significant (P > 0.05)